RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CK Life Sciences Intl (Holdings) - Stock

CK Life Sciences Intl (Holdings) ROCE 2024

CK Life Sciences Intl (Holdings) ROCE

0.06

Ticker

775.HK

ISIN

KYG2176J1058

WKN

662762

In 2024, CK Life Sciences Intl (Holdings)'s return on capital employed (ROCE) was 0.06, a -8.51% increase from the 0.06 ROCE in the previous year.

CK Life Sciences Intl (Holdings) Aktienanalyse

What does CK Life Sciences Intl (Holdings) do?

CK Life Sciences International (Holdings) Inc (CKLS) is a leading company in the field of life sciences and biotechnology, founded in Hong Kong in 1994. It is a subsidiary of CK Hutchison Holdings, one of the largest conglomerates in Asia. CKLS operates in the business sectors of agricultural sciences, health sciences, and investment. The company has international offices in Australia, the USA, Canada, China, and Europe. The agricultural sciences division of CKLS focuses on research and development of plant-based technologies, including plant breeding, agricultural production, and biological pest control. CKLS specifically engages in the development of breeding techniques that enhance the speed, efficiency, and precision of plant breeding. The goal is to increase agricultural production and reduce the ecological footprint. CKLS also has its own brand of biological plant protection products called ABOUND, which provides protection against pests and diseases. The health sciences division of CKLS encompasses research and development of pharmaceuticals and dietary supplements. The company specializes in the development of dietary supplements made from natural ingredients that are intended to promote health and well-being. An example is the probiotic BioGaia, which is used to support digestive health and treat diarrhea. CKLS also engages in the research of herbal medicine and traditional Chinese medicine. The company has launched its own product line of traditional Chinese medicine, developed based on the millennia-old healing methods of Chinese medicine. The investment division of CKLS focuses on investing in companies and innovations that aim to improve life. For example, CKLS has invested in the US company StemCells, which specializes in the research and development of stem cell transplantation for neurological disorders. Overall, CKLS offers a wide range of products and services aimed at improving people's lives and health. Based on its research and development activities in the biotech industry, the company is working to solidify its leading role in the field of life sciences and biotechnology. In summary, CKLS is a leading company in the field of life sciences and biotechnology, operating in the sectors of agricultural sciences, health sciences, and investment. The company offers a wide range of products and services aimed at improving people's lives and health. CK Life Sciences Intl (Holdings) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling CK Life Sciences Intl (Holdings)'s Return on Capital Employed (ROCE)

CK Life Sciences Intl (Holdings)'s Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing CK Life Sciences Intl (Holdings)'s ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

CK Life Sciences Intl (Holdings)'s ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in CK Life Sciences Intl (Holdings)’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about CK Life Sciences Intl (Holdings) Stock

What is the ROCE (Return on Capital Employed) of CK Life Sciences Intl (Holdings) this year?

The ROCE of CK Life Sciences Intl (Holdings) is 0.06 undefined this year.

How has the ROCE (Return on Capital Employed) of CK Life Sciences Intl (Holdings) developed compared to the previous year?

The ROCE of CK Life Sciences Intl (Holdings) has increased by -8.51% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of CK Life Sciences Intl (Holdings)?

A high Return on Capital Employed (ROCE) indicates that CK Life Sciences Intl (Holdings) has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of CK Life Sciences Intl (Holdings)?

A low ROCE (Return on Capital Employed) can indicate that CK Life Sciences Intl (Holdings) has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from CK Life Sciences Intl (Holdings) impact the company?

An increase in the ROCE of CK Life Sciences Intl (Holdings) can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of CK Life Sciences Intl (Holdings) affect the company?

A decrease in ROCE of CK Life Sciences Intl (Holdings) can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of CK Life Sciences Intl (Holdings)?

Some factors that can affect CK Life Sciences Intl (Holdings)'s ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of CK Life Sciences Intl (Holdings) so important for investors?

The ROCE of CK Life Sciences Intl (Holdings) is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can CK Life Sciences Intl (Holdings) take to improve the ROCE?

To improve the ROCE, CK Life Sciences Intl (Holdings) can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does CK Life Sciences Intl (Holdings) pay?

Over the past 12 months, CK Life Sciences Intl (Holdings) paid a dividend of 0.01 HKD . This corresponds to a dividend yield of about 2.25 %. For the coming 12 months, CK Life Sciences Intl (Holdings) is expected to pay a dividend of 0.01 HKD.

What is the dividend yield of CK Life Sciences Intl (Holdings)?

The current dividend yield of CK Life Sciences Intl (Holdings) is 2.25 %.

When does CK Life Sciences Intl (Holdings) pay dividends?

CK Life Sciences Intl (Holdings) pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of CK Life Sciences Intl (Holdings)?

CK Life Sciences Intl (Holdings) paid dividends every year for the past 13 years.

What is the dividend of CK Life Sciences Intl (Holdings)?

For the upcoming 12 months, dividends amounting to 0.01 HKD are expected. This corresponds to a dividend yield of 2.25 %.

In which sector is CK Life Sciences Intl (Holdings) located?

CK Life Sciences Intl (Holdings) is assigned to the 'Health' sector.

Wann musste ich die Aktien von CK Life Sciences Intl (Holdings) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CK Life Sciences Intl (Holdings) from 6/5/2023 amounting to 0.008 HKD, you needed to have the stock in your portfolio before the ex-date on 5/23/2023.

When did CK Life Sciences Intl (Holdings) pay the last dividend?

The last dividend was paid out on 6/5/2023.

What was the dividend of CK Life Sciences Intl (Holdings) in the year 2023?

In the year 2023, CK Life Sciences Intl (Holdings) distributed 0.01 HKD as dividends.

In which currency does CK Life Sciences Intl (Holdings) pay out the dividend?

The dividends of CK Life Sciences Intl (Holdings) are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CK Life Sciences Intl (Holdings)

Our stock analysis for CK Life Sciences Intl (Holdings) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CK Life Sciences Intl (Holdings) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.